Evidence map›Paper›PMID 42151619›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

An interpretable machine learning model integrating [

Donghe Chen, Tiancheng Li, Jianan Cui, Chunmei Yang, Zhenfeng Liu, Huang Huang, Huafeng Liu, Xinhui Su

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Donghe ChenDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
Tiancheng LiDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
Jianan CuiThe Institute of Information Processing and Automation, College of Information Engineering, Zhejiang University of Technology, Hangzhou, China.
Chunmei YangDepartment of hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
Zhenfeng LiuDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
Huang HuangDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
Huafeng LiuThe State Key Laboratory of Modern Optical Instrumentation, College of Optical Science and Engineering, Zhejiang University, Hangzhou, China. liuhf@zju.edu.cn.
Xinhui SuDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China. suxinhui@zju.edu.cn.ORCID 0000-0002-4782-3982

Funding

Medical Science and Technology Project of Zhejiang Province 2025KY055National Natural Science Foundation of China 62427807National Natural Science Foundation of China 82472013
6 · The paper itself

Abstract

backgroundPerforation following chemotherapy in gastrointestinal lymphoma (PFCGL) is a rare but severe and life-threatening complication. Early pre-chemotherapy prediction is crucial for optimizing treatment and improving outcomes, yet it remains challenging. This study aimed to develop a machine learning (ML) model combining clinical features and [ MATERIALS AND

methodsA total of 257 patients diagnosed at two hospitals with gastrointestinal lymphoma were included. Clinical data and PET/CT images were collected. PET/CT radiomics signature were extracted from the FDG-avid regions. Five ML algorithms were used to develop predictive models, including clinical, PET/CT radiomics, and clinical-PET/CT models. The SHapley Additive exPlanations (SHAP) method was applied for model interpretability.

resultsThe internal training, internal validation and external validation cohorts consisted of 144 patients (mean age: 56.90 ± 14.69 years; 88 males), 63 patients (mean age: 61.76 ± 13.71 years; 36 males) and 50 patients (mean age: 63.28 ± 12.17 years; 27 males), respectively. Among these, 22, 11, and 11 patients were diagnosed with PFCGL in the three cohorts, correspondingly. For clinical features, elevated C-reactive protein levels and pathological type of T-cell non-Hodgkin's lymphoma were risk factors for predicting PFCGL. SHAP analysis revealed that PET/CT radiomics signature significantly contributed to the prediction of PFCGL. The clinical-PET/CT model utilizing the logistic regression (LR) algorithm exhibited superior predictive performance for PFCGL compared to the individual clinical model and the PET/CT radiomics model employing the ExtraTrees algorithm. This was evidenced by the area under the curve (AUC) values of 0.918, 0.872 and 0.857 in the training cohort, 0.858, 0.795 and 0.849 in the internal validation cohort, and 0.852, 0.770 and 0.807 in the external validation cohort, respectively.

conclusionThe combined model that integrates [

Indexed as

Fluorodeoxyglucose F18Gastrointestinal NeoplasmsIntestinal PerforationLymphomaMachine LearningPositron Emission Tomography Computed TomographyRadiomicsAgedFemaleHumansMaleMiddle AgedPredictive Learning ModelsFluorodeoxyglucose F18[18F]FDG PET/CT; Machine learningGastrointestinal lymphomaPerforationSHAP

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.